- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ISR IMMUNE SYSTEM REGULATION Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIA THERAPEUTICS | 11,300 | -0,70 % | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| PACIFIC BIOSCIENCES OF CALIFORNIA | 1,184 | +1,56 % | PacBio Announces the Appointment of Chris Gibson to the Board of Directors | MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher... ► Artikel lesen | |
| ATAIBECKLEY | 3,220 | -2,42 % | Psychedelika-Investments im Aufwind: Emyria Limited und AtaiBeckley forcieren neue PTBS-Therapiestandards | ||
| BIOMERIEUX | 92,60 | -0,59 % | BioMerieux SA Profit Declines In Full Year | PARIS (dpa-AFX) - BioMerieux SA (EYWN.MU) reported earnings for full year that Drops, from the same period last yearThe company's bottom line totaled EUR397.5 million, or EUR3.34 per share.... ► Artikel lesen | |
| BIO GREEN MED SOLUTION | 1,005 | +1,13 % | Bio Green Med Solution, Inc. - 10-K, Annual Report | ||
| ANAPTYSBIO | 48,600 | -2,80 % | AnaptysBio gliedert First Tracks Biotherapeutics aus: Handel an der NASDAQ startet am 20. April | ||
| GENUS | 27,600 | -4,83 % | Genus PLC - Director/PDMR Shareholding | ||
| ABIONYX PHARMA | 3,790 | +2,29 % | ABIONYX Pharma Achieves Major Milestone in apoA-I Biomanufacturing with Breakthrough in Synthetic Sphingomyelin Production | Regulatory News:
ABIONYX Pharma, (FR0012616852 ABNX eligible for PEA PME), a next-generation biopharmaceutical company developing innovative therapies in sepsis and critical care based on an... ► Artikel lesen | |
| MEIRAGTX | 7,800 | -1,89 % | MeiraGTx Holdings plc - 10-K, Annual Report | ||
| XTL BIOPHARMACEUTICALS | 1,930 | 0,00 % | XFRA HHB0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| AKESO | 15,700 | +1,95 % | Akeso, Inc.: Akeso Reports Full-Year 2025 Financial Results | HONG KONG, March 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive... ► Artikel lesen | |
| MAAT PHARMA | 5,660 | +0,71 % | MaaT Pharma Announces Publication of Retrospective Data in Third-Line Acute GvHD from the CHRONOS Study in Bone Marrow Transplantation Journal | CHRONOS is one of the largest real-world studies including refractory GI-aGvHD patients (n=59) treated with third-line best available treatments other than microbiome-based therapy
Results... ► Artikel lesen | |
| ISOFOL MEDICAL | 0,047 | +5,84 % | Isofol Medical AB: Isofol secures license rights for arfolitixorin in autism | GOTHENBURG, Sweden, March 18, 2026 - Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the company has expanded its global exclusive license agreement for arfolitixorin to also... ► Artikel lesen | |
| DIAGONAL BIO | 0,004 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.12.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 19.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.12.2025ISIN NameCA74349R1055 PROPHECY... ► Artikel lesen |
ISR IMMUNE SYSTEM REGULATION HOLDING AB gehört der Branche Biotechnologie an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ISR IMMUNE SYSTEM REGULATION HOLDING AB finden Sie auf Wallstreet Online.